Search Results 351-360 of 18605 for alzheimers
I have been studying molecular pathogenesis of Alzheimer's disease since 1995, and I also have been testing viral gene therapy since 2005. Why and how did you ...
Last week, the Food and Drug Administration approved aducanumab to treat Alzheimer's disease, which is a progressive brain disorder that is the most common ...
This study investigated the association of genetic risk factors for late-onset Alzheimer's disease (LOAD) with risk of posterior cortical atrophy (PCA).
About 30 Mayo Clinic scientists are presenting at this week's Alzheimer's Association International Conference in Chicago, and another roughly two dozen ...
November is Alzheimer's Disease Awareness Month, a time to raise awareness of the disease while recognizing the important work that caregivers do when caring ...
And sometimes their personalities may completely change. Ronald Petersen, M.D., Ph.D. Alzheimer's disease expert. Mayo Clinic. “The person can become angry ...
... Alzheimer's Disease Research Center at Mayo Clinic. Lunde is the conference's co-director. Program highlights include: Featured speaker Jason Karlawish ...
Researchers Find “Camouflaged” Gene Regions Key to Alzheimer's and More. By. Mayo Clinic Staff. May 20, 2019 ...
Gene Nearly Triples Risk of Alzheimer's, Global Team Including Mayo Clinic Finds. JACKSONVILLE, Fla. — A gene so powerful it nearly triples the risk of ...
"When activated, human innate immunity results in inflammation, and previous research on this response to development of Alzheimer's disease has been ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.